OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 12 results.
Search:

SKU Category Vector Description Price Delivery
TA326959-100 Antibody 100 ug GRIA3 Rabbit Polyclonal Antibody $325 3 Weeks
TA338509-100 Antibody 50 ug Rabbit Polyclonal Anti-Gria3 Antibody $325 3-7 days
TA338563-100 Antibody 50 ug Rabbit Polyclonal Anti-Gria3 Antibody $325 3-7 days
SC127844 Human cDNA pCMV6-XL4 GRIA3 (untagged)-Human glutamate receptor, ionotrophic, AMPA 3 (GRIA3), transcript variant 1 NM_007325.2 $1610 Immediate
RC219063 Human ORF PS100001 GRIA3 (Myc-DDK-tagged)-Human glutamate receptor, ionotrophic, AMPA 3 (GRIA3), transcript variant 1 $1290 Immediate
RC219063L1 Human ORF PS100064 Lenti ORF clone of Human glutamate receptor, ionotrophic, AMPA 3 (GRIA3), transcript variant 1 , Myc-DDK-tagged $1660 Immediate
RC219063L2 Human ORF PS100071 Lenti ORF clone of Human glutamate receptor, ionotrophic, AMPA 3 (GRIA3), transcript variant 1, mGFP tagged $1830 3-4 weeks
RC519063 Human ORF PS100001 GRIA3 (Myc-DDK-tagged)-Human glutamate receptor, ionotrophic, AMPA 3 (GRIA3), transcript variant 1, (200ug) $1410 1-2 weeks
RG219063 Human ORF PS100010 GRIA3 (GFP-tagged) - Human glutamate receptor, ionotrophic, AMPA 3 (GRIA3), transcript variant 1 $1420 2-3 weeks
HP231917 Human Primer qSTAR qPCR primer pairs against Homo sapiens gene GRIA3 NM_007325 $95 3 - 5 Days
LC416052 Lysate TA326959 GRIA3 HEK293T cell transient overexpression lysate (as WB positive control) $50 In Stock
LY416052 Lysate LC416052 Transient overexpression lysate of glutamate receptor, ionotrophic, AMPA 3 (GRIA3), transcript variant 1 $480 5 days
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title